Positions

Selected Publications

Academic Article

Year Title Altmetric
2019 Effect of Intensive and Standard Clinic-Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINT 2019
2019 Serum Sodium and Pulse Pressure in SPRINT 2019
2018 Periprocedural Stroke and Myocardial Infarction as Risks for Long-Term Mortality in CREST 2018
2018 Drugs don’t work in patients who don’t take them 2018
2018 Race, sex, age, and regional differences in the association of obstructive sleep apnea with atrial fibrillation: Reasons for geographic and racial differences in stroke study 2018
2018 N-terminal pro-B-type natriuretic peptide and microsize myocardial infarction risk in the reasons for geographic and racial differences in stroke study 2018
2018 Long-term effects of an intensive lifestyle intervention on electrocardiographic criteria for left ventricular hypertrophy: The look AHEAD trial 2018
2018 Gender, blood pressure, and cardiovascular and renal outcomes in adults with hypertension fromthe Systolic Blood Pressure InterventionTrial 2018
2018 Serum Tumor Necrosis Factor-alpha associates with Myocardial Oxygen Demand and Exercise Tolerance in Postmenopausal Women. 2018
2017 The Effect of Intentional Weight Loss on Fracture Risk in Persons With Diabetes: Results From the Look AHEAD Randomized Clinical Trial 2017
2017 The association between insulin resistance and atrial fibrillation: A cross-sectional analysis from SPRINT (Systolic Blood Pressure Intervention Trial) 2017
2017 Adherence to high-intensity statins following a myocardial infarction hospitalization among medicare beneficiaries 2017
2017 Comparison of expert adjudicated coronary heart disease and cardiovascular disease mortality with the National Death Index: Results from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study 2017
2016 Orthostatic changes in systolic blood pressure among SPRINT participants at baseline 2016
2016 What is the association of lipid levels and incident stroke? 2016
2016 A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials investigating the effects of statin therapy on plasma lipid concentrations in HIV-infected patients 2016
2016 Prevalence of electrocardiographic abnormalities based on hypertension severity and blood pressure levels: the Reasons for Geographic and Racial Differences in Stroke study 2016
2016 Gender, race, age, and regional differences in the association of pulse pressure with atrial fibrillation: the Reasons for Geographic and Racial Differences in Stroke study 2016
2016 Is there an association between the prevalence of atrial fibrillation and severity and control of hypertension? The REasons for Geographic And Racial Differences in Stroke study 2016
2016 Antihypertensive medications and sexual function in women: Baseline data from the SBP intervention trial (SPRINT) 2016
2016 Burden of Coronary Heart Disease Rehospitalizations Following Acute Myocardial Infarction in Older Adults 2016
2016 Systolic blood pressure response after high-intensity interval exercise is independently related to decreased small arterial elasticity in normotensive African American women 2016
2016 Antidepressant Medication Use and Its Association With Cardiovascular Disease and All-Cause Mortality in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study 2016
2016 Head-to-head comparison of statins versus fibrates in reducing plasma fibrinogen concentrations: A systematic review and meta-analysis 2016
2016 Recruitment strategies and challenges in a large intervention trial: Systolic Blood Pressure Intervention Trial 2016
2015 Trends in the Use of Nonstatin Lipid-Lowering Therapy Among Patients With Coronary Heart Disease: A Retrospective Cohort Study in the Medicare Population 2007 to 2011 2015
2015 Tibolone decreases Lipoprotein(a) levels in postmenopausal women: A systematic review and meta-analysis of 12 studies with 1009 patients 2015
2015 Prospective association of a genetic risk score and lifestyle intervention with cardiovascular morbidity and mortality among individuals with type 2 diabetes: the Look AHEAD randomised controlled trial 2015
2015 Statin therapy and plasma coenzyme Q10 concentrations - A systematic review and meta-analysis of placebo-controlled trials 2015
2015 Perceived Stress and Atrial Fibrillation: The REasons for Geographic and Racial Differences in Stroke Study 2015
2015 Perceived Stress and Atrial Fibrillation: The REasons for Geographic and Racial Differences in Stroke Study 2015
2015 Systolic blood pressure control among individuals with type 2 diabetes: A comparative effectiveness analysis of three interventions 2015
2015 Partial Meal Replacement Plan and Quality of the Diet at 1 Year: Action for Health in Diabetes (Look AHEAD) Trial 2015
2015 Race-sex differences in the management of hyperlipidemia: The reasons for geographic and racial differences in stroke study 2015
2015 Changes in body composition over 8 years in a randomized trial of a lifestyle intervention: The look AHEAD study 2015
2015 Coronary Heart Disease Risk Factors and Outcomes in the Twenty-First Century: Findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study 2015
2015 Correlates of Incident Cognitive Impairment in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study 2015
2015 Effects of coenzyme Q10 on statin-induced myopathy: A meta-analysis of randomized controlled trials 2015
2015 Is pulse pressure an independent risk factor for incident stroke, REasons for geographic and racial differences in stroke 2015
2015 Should acetaminophen be added to the list of anti-inflammatory agents that are associated with cardiovascular events? 2015
2014 Implications of Look AHEAD for clinical trials and clinical practice 2014
2014 Secular changes in rates of coronary heart disease, fatal coronary heart disease, and out-of-hospital fatal coronary heart disease 2014
2014 Achievement of optimal medical therapy goals for U.S. adults with coronary artery disease: Results from the REGARDS Study (REasons for Geographic and Racial Differences in Stroke) 2014
2014 Impact of weight loss on ankle-brachial index and interartery blood pressures 2014
2014 Arterial elasticity, strength, fatigue, and endurance in older women 2014
2014 Prehypertension and incident acute coronary heart disease in the reasons for geographic and racial differences in stroke (Regards) study 2014
2014 Aspirin as Primary Prevention of Acute Coronary Heart Disease Events. 2014
2014 Cognitive effects of statin medications 2014
2014 Declines in coronary heart disease incidence and mortality among middle-aged adults with and without diabetes 2014
2014 Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: A secondary analysis of the Look AHEAD randomised clinical trial 2014
2014 Hemodynamic and echocardiographic profiles in african american compared with white offspring of hypertensive parents: The HyperGEN study 2014
2014 Is pulse pressure an independent risk factor for incident acute coronary heart disease events? the REGARDS study 2014
2014 Objective sleep, a novel risk factor for alterations in kidney function: The CARDIA study 2014
2014 Statin underuse and low prevalence of LDL-C control among U.S. Adults at high risk of coronary heart disease 2014
2013 Perceived stress is associated with incident coronary heart disease and all-cause mortality in low- but not high-income participants in the Reasons for Geographic And Racial Differences in Stroke study 2013
2013 Longitudinal associations between objective sleep and lipids: The CARDIA study 2013
2013 Awareness, treatment, and control of LDL cholesterol are lower among U.S. adults with undiagnosed diabetes versus diagnosed diabetes 2013
2013 Longitudinal determinants of left ventricular mass and geometry: The coronary artery risk development in young adults (CARDIA) study 2013
2013 Trends in the prevalence, awareness, treatment and control of high low density lipoprotein-cholesterol among United States adults from 1999-2000 Through 2009-2010 2013
2013 Hospital laboratory reporting may be a barrier to detection of 'microsize' myocardial infarction in the US: An observational study 2013
2013 Four-year change in cardiorespiratory fitnessandinfluenceonglycemiccontrol in adults with type 2 diabetes in a randomized trial: The look AHEAD trial 2013
2013 Associations between arterial elasticity and markers of inflammation in healthy older women 2013
2013 Changes in Vascular Hemodynamics in Older Women Following 16 Weeks of Combined Aerobic and Resistance Training 2013
2013 Assessment tools for unrecognized myocardial infarction: A cross-sectional analysis of the REasons for geographic and racial differences in stroke population 2013
2013 Primary prophylactic aspirin use and incident stroke: Reasons for geographic and racial differences in stroke study 2013
2012 Association of race and sex with risk of incident acute coronary heart disease events 2012
2012 Effects of antihypertensive drugs on arterial stiffness 2012
2012 Blood pressure indexes and end-stage renal disease risk in adults with chronic kidney disease 2012
2012 Is funding source related to study reporting quality in obesity or nutrition randomized control trials in top-tier medical journals 2012
2012 Both morning and evening dosing of nebivolol reduces trough mean blood pressure surge in hypertensive patients 2012
2012 Is randomization to placebo safe? Risk in placebo-controlled angina trials: Angina risk meta-analysis 2012
2012 Subclinical, hemodynamic, and echocardiographic abnormalities of high pulse pressure in hypertensive and non-hypertensive adults. 2012
2011 A clustering analysis of lipoprotein diameters in the metabolic syndrome 2011
2011 The Global Burden of Cardiovascular Disease: The Role of Endothelial Function and Arterial Elasticity in Cardiovascular Disease as Novel and Emerging Biomarkers 2011
2011 High-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering drugs and diet network (GOLDN): An interventional study 2011
2011 Four-year weight losses in the look AHEAD study: Factors associated with long-term success 2011
2011 Lipoprotein Lipase S447X variant associated with VLDL, LDL and HDL diameter clustering in the MetS 2011
2011 Myocardial infarction after carotid stenting and endarterectomy: Results from the carotid revascularization endarterectomy versus stenting trial 2011
2011 Prehypertension, racial prevalence and its association with risk factors: Analysis of the reasons for geographic and racial differences in stroke (REGARDS) study 2011
2010 Effect of the Look AHEAD study intervention on medication use and related cost to treat cardiovascular disease risk factors in individuals with type 2 diabetes 2010
2010 Trust in physicians and blood pressure control in blacks and whites being treated for hypertension in the REGARDS study 2010
2010 The association of statin use and statin type and cognitive performance: Analysis of the reasons for geographic and racial differences in stroke (REGARDS) study 2010
2010 Comparison of Postprandial Responses to a High-Fat Meal in Hypertriglyceridemic Men and Women before and after Treatment with Fenofibrate in the Genetics and Lipid Lowering Drugs and Diet Network (GOLDN) Study. 2010
2009 Does prehypertension represent an increased risk for incident hypertension and adverse cardiovascular outcome? 2009
2009 TCF7L2 polymorphisms and inflammatory markers before and after treatment with fenofibrate. 2009
2009 Smoking, inflammatory patterns and postprandial hypertriglyceridemia 2009
2009 Clinical benefits versus shortcomings of diltiazem once-daily in the chronotherapy of cardiovascular diseases 2009
2008 Measurement characteristics of the ankle-brachial index: Results from the action for health in diabetes study 2008
2008 Weight loss treatment influences untreated spouses and the home environment: Evidence of a ripple effect 2008
2008 Does differential prophylactic aspirin use contribute to racial and geographic disparities in stroke and coronary heart disease (CHD)? 2008
2008 The risks associated with short-term placebo-controlled antihypertensive clinical trials: A descriptive meta-analysis 2008
2008 Association between endothelial biomarkers and arterial elasticity in young adults: the CARDIA Study 2008
2008 Vascular stiffness and the "chicken-or-the-egg" question 2008
2008 Analysis of US food and drug administration warning letters: False promotional claims relating to prescription and over-the-counter medications 2008
2008 Endothelial function in young adult survivors of childhood acute lymphoblastic leukemia 2008
2007 Importance and challenges of studying marketed drugs: What is a phase IV study? common clinical research designs, registries, and self-reporting systems 2007
2007 Diagnostic criteria and adjudication process both determine published event-rates: The ACTION trial experience 2007
2007 Health Knowledge About Symptoms of Heart Attack and Stroke in Adult Survivors of Childhood Acute Lymphoblastic Leukemia 2007
2006 Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) study 2006
2006 Consent for genetics studies among clinical trial participants: Findings from action for health in diabetes (Look AHEAD) 2006
2006 Clinical trial design issues: At least 10 things you should look for in clinical trials 2006
2006 Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia 2006
2006 Antihypertensive safety and efficacy and physicians and patient satisfaction: Results from a phase 4 practice-based clinical experience trial with diltiazem LA 2006
2006 Pharmacogenetics of antihypertensive treatment 2006
2006 Cardiovascular events in hypertension trials: A focus on perindopril 2006
2005 Is HDL cholesterol an independent cardiovascular disease risk factor? 2005
2005 The obesity epidemic: New therapeutic approaches 2005
2005 Part 3: Overview of study designs 2005
2005 Long-acting diltiazem HCL for the chronotherapeutic treatment of hypertension and chronic stable angina pectoris 2005
2005 Essential characteristics of clinical research and strength of evidence 2005
2005 Efficacy and safety of a once-daily graded-release diltiazem formulation dosed at bedtime compared to placebo and to morning dosing in chronic stable angina pectoris 2005
2004 Clinical research: Definitions, "anatomy and physiology," and universal truth 2004
2004 Polypharmacy - The good, the bad, and the ugly 2004
2004 Determinants of radial artery pulse wave analysis in asymptomatic individuals 2004
2003 Diltiazem Hydrochloride: New Technologies and Evolution of Diltiazem 2003
2003 Revisiting erectile dysfunction in cardiovascular patients 2003
2003 Reduced small artery but not large artery elasticity is an independent risk marker for cardiovascular events 2003
2003 Efficacy and safety of a once daily graded-release diltiazem formulation in essential hypertension 2003
2002 The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease 2002
2002 Hypertension syndrome and cardiovascular events 2002
2002 Effect of doxazosin on arterial elasticity: Functional versus structural changes 2002
2002 Extended-release fluvastatin 80 mg shows greater efficacy, with comparable tolerability, versus immediate-release fluvastatin 40 mg for once daily treatment of primary hypercholesterolaemia 2002
2002 Safety of PDE 5 inhibition in patients with cardiovascular disease 2002
2002 SERMs revisited 2002
2001 Arterial compliance abnormalities in isolated systolic hypertension 2001
2001 Low-density lipoprotein size, pravastatin treatment, and coronary events 2001
2001 Blood pressure and arterial compliance in young adults: The Minnesota Children's Blood Pressure Study 2001
2001 Hypertension syndrome and cardiovascular events: High blood pressure is only one risk factor 2001
2001 Safety of combination therapy for treatment of dyslipidemia 2001
2001 Treating hypertension in the elderly - Whom to treat, when, and with what? 2001
2000 Will angiotensin receptor blockers play a role in heart failure treatment? 2000
2000 On Arterial Physiology, Pathophysiology of Vascular Compliance, and Cardiovascular Disease 2000
2000 Angiotensin converting enzyme inhibitors: Are they preferred first-line therapy? 2000
2000 Circadian heart rate response to chronotherapy versus conventional therapy in patients with hypertension and myocardial ischemia 2000
1999 Circadian Variations and Chronotherapeutic Implications for Cardiovascular Management: A Focus on COER Verapamil 1999
1999 New physiologic therapy for diabetes 1999
1999 Prospects for therapy of nitrate tolerance 1999
1999 Anti-ischemic effects of Amlodipine in patients with stable angina pectoris and myocardial ischemia during daily life 1999
1999 Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris 1999
1999 Age-related abnormalities in arterial compliance identified by pressure pulse contour analysis: Aging and arterial compliance 1999
1998 Hormone replacement therapy: Should it be routine? 1998
1998 Clinical trials of herbal supplements to begin 1998
1998 Sildenafil: Possible pitfalls for the heart patient 1998
1998 Novel approaches to heart failure 1998
1998 Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range: Results of the cholesterol and recurrent events (CARE) trial 1998
1998 Effect of pravastatin on cardiovascular events in women after myocardial infarction: The Cholesterol and Recurrent Events (CARE) trial 1998
1998 Additional antianginal and anti-ischemic efficacy of mibefradil in patients concomitantly treated with long-acting nitrates for chronic stable angina pectoris 1998
1998 Chronotherapeutics in cardiovascular disease 1998
1998 Estrogen/progestin therapy: Putting the HERS results in context 1998
1998 Hypertension, hypertrophy, hormones, and the heart 1998
1998 Single-pill combination therapy 1998
1998 The importance of arterial compliance in cardiovascular drug therapy 1998
1998 The relevance of T-type calcium antagonists: A profile of mibefradil 1998
1998 Toward the ideal target goal for lowering cholesterol 1998
1997 Effect of extended-release isosorbide mononitrate one hour after dosing in patients with stable angina pectoris 1997
1997 Advances in antiplatelet therapy (continued) 1997
1997 Beta blocking agents in congestive heart failure 1997
1997 New treatment options for diabetes mellitus 1997
1997 Vascular compliance and cardiovascular disease: A risk factor or a marker? 1997
1997 The time course of left ventricular remodeling after acute myocardial infarction 1997
1997 Antianginal response to once-daily diltiazem CD in patients receiving concomitant β-blockers, long-acting nitrates, or both 1997
1997 Effects of zatebradine (ULFS 49 CL), a sinus node inhibitor, on heart rate and exercise duration in chronic stable angina pectoris 1997
1997 Eccentric dosage regimen for isosorbide dinitrate 1997
1997 Eccentric dosage regimen for isosorbide dinitrate. 1997
1997 Safety and efficacy of monotherapy with fantofarone, a novel calcium channel antagonist, in patients with chronic stable angina pectoris 1997
1996 Chronobiology and chronotherapeutics 1996
1996 Atherosclerosis: Risk factors and the vascular endothelium 1996
1996 The efficacy and safety of Pravastatin in patients aged 60 to 85 years with low-density lipoprotein cholesterol > 160 mg/dl 1996
1996 The placebo effect in cardiovascular disease 1996
1995 Nisoldipine coat core as concomitant therapy in chronic stable angina pectoris 1995
1995 Antianginal and Antiischemic Efficacy of Monotherapy Extended‐Release Nisoldipine (Coat Core) in Chronic Stable Angina 1995
1995 Reply 1995
1995 The efficacy and safety of once-daily nifedipine administered without food: the coat-core formulation compared with the gastrointestinal therapeutic system formulation in patients with mild-to-moderate hypertension 1995
1995 The efficacy and safety of once-daily nifedipine: the coat-core formulation compared with the gastrointestinal therapeutic system formulation in patients with mild-to-moderate diastolic hypertension 1995
1994 Mononitrates: Defining the ideal long-acting nitrate 1994
1994 Dose-response evaluation of once-daily therapy with a new formulation of diltiazem for stable angina pectoris 1994
1994 Uniformity of captopril benefit in the SAVE study: Subgroup analysis 1994
1994 Antianginal and anti-ischemic efficacy of immediate-release nisoldipine in chronic stable angina pectoris 1994
1994 Safety and compatibility of betaxolol hydrochloride combined with diltiazem or nifedipine therapy in stable angina pectoris 1994
1994 Phenomenon of nitrate tolerance 1994
1994 The role of coronary tone and increased demand in daily ischemia [1] 1994
1993 Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris 1993
1993 Is the site of maximal coronary artery narrowing the culprit for future myocardial infarction? 1993
1993 Subsets of ambulatory myocardial ischemia based on heart rate activity. Circadian distribution and response to anti-ischemic medication. The Angina and Silent Ischemia Study Group (ASIS) 1993
1993 Discordance between effects of anti-ischemic therapy on ambulatory ischemia, exercise performance and anginal symptoms in patients with stable angina pectoris 1993
1993 Endothelium-derived vasoactive substances in myocardial ischemia 1993
1993 Subsets of ambulatory myocardial ischemia based on heart rate activity: Circadian distribution and response to anti-ischemic medication 1993
1992 Amlodipine combined with beta blockade for chronic angina: Results of a multicenter, placebo‐controlled, randomized double‐blind study 1992
1992 Safety And Efficacy of Metoprolol in the Treatment of Hypertension in the Elderly 1992
1991 Clinical aspects of silent myocardial ischemia in China 1991
1991 Exposing Patients With Chronic, Stable, Exertional Angina to Placebo Periods in Drug Trials 1991
1991 Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris 1991
1991 Update on Nitrate Therapy 1991
1990 Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms 1990
1990 Long‐Term Therapy with Benazepril in Patients with Congestive Heart Failure: Effects on Clinical Status and Exercise Tolerance 1990
1990 The risk factor profile for patients with asymptomatic myocardial ischemia 1990
1990 Update on nitrate therapy: Reexamination of tolerance issues and efficacy endpoints of long-acting products 1990
1989 Effects of dilevalol, metoprolol and atenolol on left ventricular mass and function in nonelderly and elderly hypertensive patients 1989
1989 Influence of beta2 agonism and beta1 and beta2 antagonism on adverse effects and plasma lipoproteins: Results of a multicenter comparison of dilevalol and metoprolol 1989
1989 Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina 1989
1989 Safety and efficacy of amlodipine added to hydrochlorothiazide therapy in essential hypertension. 1989
1989 Clinical safety and efficacy of once-daily amlodipine for chronic stable angina pectoris 1989
1989 Predictors of left ventricular hypertrophy in patients with essential hypertension 1989
1989 Regression of Left Ventricular Hypertrophy in Treated Hypertensive Patients with Dilevalol and Metoprolol—A Double Blind Randomized Study 1989
1989 Safety and efficacy of amlodipine added to hydrochlorothiazide therapy in essential hypertension 1989
1989 Silent myocardial ischemia: Improvement with nisoldipine therapy 1989
1989 The Efficacy and Safety of Dilevalol in Patients with Chronic Stable Angina Pectoris 1989
1989 The Impact of Antianginal Drug Therapy on Asymptomatic Myocardial Ischemia 1989
1988 Clinical safety and efficacy of once-a-day amlodipine for chronic stable angina pectoris 1988
1988 Clinical assessment of beta blockade 1988
1988 Dilevalol compared to metoprolol for treatment of hypertension: A multicenter trial 1988
1988 Effect of intravenous isosorbide dinitrate versus nitroglycerin on elevated pulmonary arterial wedge pressure during acute myocardial infarction 1988
1988 Relation of results of exercise stress tests in young women to phases of the menstrual cycle 1988
1987 A paradoxical response to arrhythmia therapy 1987
1986 The role of exercise testing in the identification of patients with silent myocardial ischemia 1986
1985 Management of cardiac arrhythmias 1985
1984 Exercise-induced S-T segment alterations. 1984
1984 Predischarge post-myocardial infarction testing: exercise electrocardiography. 1984
1984 Symposium on clinical exercise testing. Introduction and overview. 1984
1984 Comparison of nitrendipine combined with low-dose hydrochlorothiazide to hydrochlorothiazide alone in mild to moderate essential hypertension 1984
1983 Comparison of the antiarrhythmic effects of acebutolol and propranolol in the treatment of ventricular arrhythmias 1983
1982 Pulmonary valve echogram 1982
1982 The independent impact of M-mode echocardiography on the diagnosis of suspected endocarditis 1982
1982 The rhythms of aging. What new do we know from Holter monitoring? 1982
1981 An automated system for blood pressure determination during exercise 1981
1981 Bayes' theorem in perspective: Toward improved interpretation of the exercise test 1981
1980 Cardiovascular and sympathetic reactions to in-flight emergency responses among base fire fighters 1980
1980 Arrhythmias detected by ambulatory monitoring. Lack of correlation with symptoms of dizziness and syncope 1980
1980 Chloral hydrate overdose and cardiac arrhythmias 1980
1980 Exercise and coronary artery disease 1980
1979 When cardiac patients become surgical patients 1979
1979 Electrocardiogram of the month. A node of caution. 1979
1979 Preanesthetic Management of the Hypertensive Patient 1979
1979 Electrocardiogram of the month. The breaking point. 1979
1979 Electrocardiogram of the month: run silent run deep. 1979
1979 Three is company. 1979
1979 Atrial fibrillatory wave size and etiology of heart disease 1979
1979 Echocardiographic incidence of pericardial effusion in patients resuscitated by emergency medical technicians 1979
1979 Occurrence of frequent complex arrhythmias detected by ambulatory monitoring. Findings in an apparently healthy asymptomatic elderly population 1979
1978 Heart rate response to 'fright stress' 1978
1978 The electrocardiogram in patients with congenital absence of the pectoralis major muscle. 1978
1978 Twenty-four hours with the happy Holter. 1978
1978 Electrocardiogram of the month: up, up and away. 1978
1978 Problems of dental patients with cardiovascular disease 1978
1978 Heartbreak or headache? 1978
1978 Pulmonary valve echography: Review and update 1978
1978 Traumatic coronary artery fistula 1978
1977 Electrocardiogram of the month. Uncommon cause for pause. 1977
1977 Ventricular asynergy 1977
1977 Electrocardiogram of the month: A message in massage. 1977
1977 A heart matter or the gallbladder? 1977
1977 The pre-excitation syndromes. 1977
1977 Atrial flutter. Tracing an elusive arrhythmia 1977
1977 Posterior leaflet motion in mitral stenosis 1977
1977 Pulmonary valve fluttering in subpulmonic ventricular septal defect 1977
1977 The arrhythmogenic effect of static electricity on the dog heart 1977
1977 The problems of patients with cardiovascular disease undergoing dental treatment. 1977
1976 Accentuate the negative - eliminate the positive. 1976
1976 Right cervical aortic arch and aortic stenosis: a case report. 1976
1976 What the internist should know about echocardiography. 1976
1976 Electrocardiogram of the month. 1976
1976 Illustrative echocardiogram: late mitral valve opening in aortic regurgitation. 1976
1976 Electrocardiogram of the month. Battle of the bulge. 1976
1976 Late mitral valve opening in aortic regurgitation 1976
1976 Left atrial size in patients with atrial fibrillation: an echocardiographic study 1976
1976 Three unusual complications resulting from attempted repair of partial anomalous pulmonary venous drainage 1976
1975 Acute rheumatic fever 1975
1975 On the QT. 1975
1975 Rapid atrial stimulation for the conversion of arrhythmias. 1975
1975 Bacterial Endocarditis: Occurrence on a Traumatically Ruptured Aortic Valve 1975
1975 Electrocardiogram of the month. 1975
1975 Electrocardiogram of the month. 1975
1975 His bundle electrogram in trifascicular disease: Report of a case studied with His bundle electrograms 1975
1974 Fixation of I.V. Catheters 1974
1974 Electrocardiogram of the month 1974
1974 Hyperactive carotid sinus reflex and his bundle electrography 1974
1974 Venospasm during cardiac catheterization 1974
1974 Venospasm during cardiac catheterization 1974
1973 Synchronized versus nonsynchronized electrocardioversion 1973
1973 Atrial injury current in pericarditis. 1973
1973 Atrial Injury Current in Pericarditis 1973
1973 Renal abnormalities discovered by routine postangiography abdominal films 1973
1973 Thrombogenicity of guide wires 1973
1972 Interpretation of intraventricular block on a trifascicular basis 1972
1972 Paroxysmal atrial tachycardia: a presenting manifestation of hyperthyroidism: case report. 1972
1972 Friedreich's ataxia and myocardiopathies 1972
1972 Thirty-two cases of interventricular septal defect and aortic insufficiency. Clinical, hemodynamic and surgical features 1972
1971 Intracavitary Electrocardiography as a Guide to Pacemaker Positioning 1971
1971 Hypertrophic obstructive cardiomyopathy and Friedreich's ataxia 1971
1971 Intermittent isolated left posterior fascicular block. 1971
1971 Left atrial myxoma. Report of a case including hemodynamic, surgical, histologic and histochemical characteristics 1971
1971 Salivary gland hemorrhage as a complication of anticoagulation therapy 1971
1970 Hypertrophic subaortic stenosis occurring in a patient with Friedreich's ataxia. 1970
1970 Blood pressure in pulmonary fibrosis. 1970
1970 Salivary gland hemorrhage-An unusual complication of Coumadin anticoagulation 1970
1968 Tuberculous pericarditis: is limited pericardial biopsy sufficient for diagnosis? Report of two cases. 1968
1968 Pituitary “Stone” An Unusual Calcification 1968
1968 Isolated massive chylopericardium 1968
1967 The pulse rate in falciparum malaria: a clinical note. 1967

Book

Year Title Altmetric
2014 Essentials of clinical research, second edition 2014
2008 Essentials of clinical research 2008

Chapter

Year Title Altmetric
2015 Stroke and hypertension in high-risk African Americans.  71-93. 2015
2014 A focus on clinical trials.  33-74. 2014
2014 Alternative interventional study designs.  75-90. 2014
2014 Association, cause, and correlation.  345-362. 2014
2014 Bias, confounding, and effect modification (interaction).  363-372. 2014
2014 Data safety and monitoring boards (DSMBs).  193-202. 2014
2014 Grant and manuscript writing.  391-418. 2014
2014 Introduction to clinical research concepts, essential characteristics of clinical research, overview of clinical research study designs.  11-32. 2014
2014 It’s all about uncertainty.  373-390. 2014
2014 Mentoring and advising.  427-435. 2014
2014 Meta-analysis, evidence-based medicine, and clinical guidelines.  203-231. 2014
2014 Phase 4 (postmarketing) research.  91-116. 2014
2014 Presentation skills: How to present research results.  437-447. 2014
2014 Recruitment and retention in clinical research.  177-192. 2014
2014 Research methodology for studies of diagnostic tests.  313-326. 2014
2014 The beginning – historical aspects of clinical research, clinical research: Definitions, “anatomy and physiology,” and the quest for “universal truth”.  1-10. 2014
2014 The media and clinical research.  419-425. 2014
2014 The placebo and nocebo effect.  145-176. 2014
2014 The role of the USA food and drug administration in clinical research.  117-143. 2014
2008 Alternative interventional study designs.  63-71. 2008
2008 Association, cause, and correlation.  279-294. 2008
2008 Bias, confounding, and effect modification.  295-302. 2008
2008 Clinical research: Definitions, anatomy and physiology, and the quest for universal truth.  3-11. 2008
2008 Clinical trials.  29-62. 2008
2008 Data safety and monitoring boards (DSMBs).  151-158. 2008
2008 Grant writing.  317-325. 2008
2008 Introduction to clinical research and study designs.  13-27. 2008
2008 It's all about uncertainty.  303-316. 2008
2008 Mentoring and advising.  335-340. 2008
2008 Meta-analysis.  159-177. 2008
2008 Postmarketing research.  73-91. 2008
2008 Presentation skills: How to present research results.  341-349. 2008
2008 Recruitment and retention.  141-149. 2008
2008 Research methodology for studies of diagnostic tests.  245-257. 2008
2008 The United States Federal Drug Administration (FDA) and clinical research.  93-110. 2008
2008 The media and clinical research.  329-333. 2008
2008 The placebo and nocebo effect.  111-140. 2008
2005 The Placebo Effect in Cardiovascular Disease.  2-28. 2005

Principal Investigator On

  • Private Grant  awarded by Bayer HealthCare 2012 - 2017
  • Private Grant  awarded by Novartis Pharma AG 2013 - 2014
  • Private Grant  awarded by Bayer AG 2008 - 2011
  • Private Grant  awarded by FOREST RESEARCH INSTITUTE, INC. 2009 - 2011
  • Investigator On

  • Private Grant  awarded by Bayer HealthCare 2015 - 2019
  • Private Grant  awarded by ASTRAZENECA AB 2013 - 2016
  • Exploring the Impact of Negative Energy Balance in Men with Prostate Cancer  awarded by National Cancer Institute/NIH/DHHS 2012 - 2016
  • Exercise Intensity, Metabolic Rate & Insulin Sensitivity  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2010 - 2016
  • Action For Health In Diabetes Continuation (Look AHEAD)  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2013 - 2016
  • Genomewide Association Study of Lipid Response to Fenofibrate and Dietary Fat  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS 2015
  • HyperGEN: Genetics of Left Ventricular Hypertrophy  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS 2013 - 2015
  • REasons for Geographic And Racial Differences in Stroke-Myocardial Infarction-2  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS 2011 - 2015
  • UAB Pre-Doctoral Training Program in Obesity-Related Research  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS 2010 - 2015
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION 2014 - 2015
  • Private Grant  awarded by Bayer HealthCare 2014 - 2015
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION 2013 - 2014
  • Genomewide Association Study of Lipid Response to Fenofibrate and Dietary Fat  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS 2008 - 2014
  • Private Grant  awarded by AMGEN, INC. 2013 - 2014
  • Longitudinal Changes in Pericardial Adiposity and Subclinical Atherosclerosis  awarded by VANDERBILT UNIVERSITY MEDICAL CENTER 2013 - 2014
  • Clinical Center for LookAHEAD: Action for Health in Diabetes  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2006 - 2013
  • Longitudinal Changes in Pericardial Adiposity and Subclinical Atherosclerosis - Field Study  awarded by WAKE FOREST UNIVERSITY 2010 - 2013
  • Longitudinal Studies of Coronary Heart Disease Risk Factors in Young Adults-CARDIA-Field Center (Coronary Artery Risk Development in Young Adults (CARDIA) Study-Field Center and Study Follow-Up Field Center)  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS 1983 - 2013
  • Hypergen: Genetics of Left Ventricular Hypertrophy  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS 2006 - 2013
  • Private Grant  awarded by AMGEN, INC. 2012 - 2013
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2012
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2012
  • Etiology of Geographic and Racial Differences in Stroke  awarded by National Institute of Neurological Disorders and Stroke/NIH/DHHS 2008 - 2012
  • Improvement of Visual Processing in Older Adults  awarded by National Institute on Aging/NIH/DHHS 2006 - 2012
  • Full Name

  • Stephen Glasser